Prevalence of long-term mechanical insufflation-exsufflation in children with neurological conditions: a population-based study.
Journal
Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
accepted:
25
11
2020
pubmed:
5
1
2021
medline:
22
9
2021
entrez:
4
1
2021
Statut:
ppublish
Résumé
To determine the prevalence of long-term mechanical insufflation-exsufflation (MI-E) and concomitant mechanical ventilation in children with neurological conditions, with reported reasons behind the initiation of treatment. This was a population-based, cross-sectional study using Norwegian national registries and a questionnaire. In total, 114 of 19 264 children with a neurological condition had an MI-E device. Seventy-three of 103 eligible children (31 females, 42 males), median (min-max) age of 10 years 1 month (1y 5mo-17y 10mo), reported their MI-E treatment initiation. Overall, 76% reported airway clearance as the main reason to start long-term MI-E. A prophylactic use was mainly reported by children with neuromuscular disorders (NMDs). Prevalence and age at initiation differed by diagnosis. In spinal muscular atrophy and muscular dystrophies, MI-E use was reported in 34% and 7% of children, of whom 83% and 57% respectively received ventilator support. One-third of the MI-E users were children with central nervous system (CNS) conditions, such as cerebral palsy and degenerative disorders, and ventilator support was provided in 31%. The overall use of concomitant ventilatory support among the long-term MI-E users was 56%. The prevalence of MI-E in a neuropaediatric population was 6 per 1000, with two-thirds having NMDs and one-third having conditions of the CNS. The decision to initiate MI-E in children with neurological conditions relies on clinical judgment. The prevalence and age at initiation of mechanical insufflation/exsufflation (MI-E) differed between diagnoses. MI-E was most commonly used in spinal muscular atrophy, where it generally coincided with ventilatory support. One-third of MI-E devices were given to children with central nervous system conditions, and one-third also received ventilatory support.
Identifiants
pubmed: 33393110
doi: 10.1111/dmcn.14797
pmc: PMC8048789
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
537-544Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.
Références
Chest. 2000 Nov;118(5):1390-6
pubmed: 11083691
Respir Care. 2020 Feb;65(2):135-143
pubmed: 31690614
Pediatr Pulmonol. 2015 Oct;50(10):1033-8
pubmed: 25327770
J Child Neurol. 2014 May;29(5):646-53
pubmed: 24022110
Thorax. 2012 Jul;67 Suppl 1:i1-40
pubmed: 22730428
Pediatr Pulmonol. 2020 Feb;55(2):510-513
pubmed: 31909568
Dev Med Child Neurol. 2021 Jan;63(1):75-80
pubmed: 32314347
Paediatr Respir Rev. 2009 Mar;10(1):18-24
pubmed: 19203740
Neuromuscul Disord. 2018 Mar;28(3):289-298
pubmed: 29395673
Eur Respir J. 2003 Mar;21(3):502-8
pubmed: 12662009
Arch Dis Child. 2011 May;96(5):426-32
pubmed: 20573738
J Phys Ther Sci. 2014 Mar;26(3):389-91
pubmed: 24707090
Respir Care. 2018 Feb;63(2):187-193
pubmed: 29066586
Dev Med Child Neurol. 2019 Jun;61(6):646-653
pubmed: 30320434
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Respir Care. 2018 Dec;63(12):1506-1513
pubmed: 30206128
Child Care Health Dev. 2019 Sep;45(5):754-771
pubmed: 31276598
Respir Med. 2018 Mar;136:98-110
pubmed: 29501255
Pediatr Pulmonol. 2018 Oct;53(10):1378-1386
pubmed: 30129703
Paediatr Respir Rev. 2018 Jun;27:69-73
pubmed: 29239774